Emerging therapies for neuropathic pain

Bibliography

• SIMMONS Z, FELDMAN EL: Update on diabetic neuropathy. Cuff. Opin. Neurol. (2002) 15:595–603.
   PubMed Web of Science ®Google Scholar
• SCHMADER KE: Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy. Clin. J. Pain (2002) 18:350–354.
   PubMed Web of Science ®Google Scholar
• BACKONJA M, SERRA J: Pharmacologic management part 1: better-studied neuropathic pain diseases. Pain Medicine 5 (2004) S28–S47.
   Google Scholar
• WOOLF CJ, SALTER MW: Neuronal plasticity: increasing the gain in pain. Science (2000) 288:1565–1569.
   PubMed Web of Science ®Google Scholar
• KINGERY WS: A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes. Pain (1997) 73:123–139.
   PubMed Web of Science ®Google Scholar
• ••A very informative review of availableclinical data in peripheral neuropathic pain and complex regional pain syndrome.
   Google Scholar
• SINDRUP SH, JENSEN TS: Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain (1999) 83:389–400.
   PubMed Web of Science ®Google Scholar
• •Comprehensive review of efficacy and safety data from a range of different neuropathic clinical trials.
   Google Scholar
• COLLINS SL, MOORE RA, MCQUAY HJ, WIFFEN P: Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review. J. Pain Sympt. Manag. (2000) 20:449–458.
   PubMed Web of Science ®Google Scholar
• GALER BS: Neuropathic pain of peripheral origin: advances in pharmacologic treatment. Neurology (1995) 45:(Suppl. 9):517–525.
   Google Scholar
• WATSON CP, TUNKS E: Neuralgia. In: Therapeutic choices. Gray J. (Ed). Ottawa: Canadian Pharmacists Association. (1998):113–119.
   Google Scholar
• WATSON CP, EVANS RJ, REED K et al: Amitriptyline versus placebo in postherpetic neuralgia. Neurology (1982) 32: 671–673.
   Google Scholar
• MAX MB, CULNANE M, SCHAFER SC et al: Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology (1987) 37:589–596.
   PubMed Web of Science ®Google Scholar
• SINDRUP SH, BROSEN K, GRAM LF: Antidepressants in pain treatment: antidepressant or analgesic effect? Clin. Neuropharmacol. (1992) 15:636A–637A.
   Google Scholar
• EGBUNIKE IG, CHAFFEE BJ: Antidepressants in the management of chronic pain syndromes. Pharmacotherapy (1990) 10:262–270.
   PubMed Web of Science ®Google Scholar
• KOPF A, RUF W: Novel drugs for neuropathic pain. Curr. Opin. Anaesthesiol. (2000) 13:577–583.
   PubMedGoogle Scholar
• MCQUAY H, TRAMER M, NYE B, CARROL D, WIFFEN PJ, MOORE RA: A systematic review of antidepressants in neuropathic pain. Pain (1996) 68:217–227.
   PubMed Web of Science ®Google Scholar
• HWANG AS, WILCOX GL: Analgesic properties of intrathecally administered heterocyclic antidepressants. Pain (1987) 28:343–355.
   PubMed Web of Science ®Google Scholar
• BASBAUM Al, FIELDS HL: Endogenous pain control mechanisms: review and hypothesis. Ann. NeuroL (1978) 4:451–462.
   PubMed Web of Science ®Google Scholar
• FIELDS HL, HEINRICHER MM, MASON P: Neurotransmitters in nociceptive modulatory circuits. Ann. Rev. Neurosci. (1991) 14:219–245.
   PubMed Web of Science ®Google Scholar
• MATTIA C, PAOLETTI F, COLUZZI F, BOANELLI A: New antidepressants in the treatment of neuropathic pain. Minerva AnestesioL (2002) 68:105–114.
   PubMedGoogle Scholar
• •Useful review comparing efficacy and potential mechanisms of new and existing antidepressants in neuropathic pain.
   Google Scholar
• DEFFOIS A. FAGE D, CARTER C: Inhibition of synaptosomal veratridine-induced sodium influx by antidepressants and neuroleptics used in chronic pain. Neurosci. Lett. (1996) 220:117–120.
   PubMed Web of Science ®Google Scholar
• EISENACH JC, GEBHART GF: Intrathecal amitriptyline acts as an N-methly-D-aspartate receptor antagonist in the presence of inflammatory hyperalgesia in rats. Anesthesiology (1995) 83:(5):1046–1054.
   PubMed Web of Science ®Google Scholar
• LIPMAN AG: Analgesic drugs for neuropathic and sympathetically maintained pain. Clin. Geriatr. Med. (1996) 12:501–515.
   PubMed Web of Science ®Google Scholar
• SMITH AJ: The analgesic effects of selective serotonin reuptake inhibitors. Psycopharmac. (1998) 12:407–413.
   PubMed Web of Science ®Google Scholar
• SINDRUP SH, BROSEN K, GRAM LF: The mechanism of action of antidepressants in pain treatment: controlled cross-over studies in diabetic neuropathy. Clin. NeuropharmacoL (1992) 15:380A–381A.
   Google Scholar
• WATSON CPN, TYLER KL, BICKERS DR, MILLIKIN LE, SMITH S, COLEMAN E: A randomised vehicle- controlled trial of topical capsaicin in the treatment of postherpetic neuralgia. Clin. Ther. (1993) 15:510–526.
   PubMed Web of Science ®Google Scholar
• MAX MB, LYNCH SA, MAIR J, SHOAF SE, SMOLLER B, DUBNER R: Effects of disipramine, amitriptyline and fluoxetine on pain in diabetic neuropathy. N Engl. J. Med. (1992) 326:1250–1256.
   PubMed Web of Science ®Google Scholar
• MUTH EA, HASKINS JT, MOYER JA, HUSBANDS GE, NIELSEN ST, SIGG EB: Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative. Biochem. PharmacoL (1986) 35:4493–4497.
   PubMed Web of Science ®Google Scholar
• HASKINS JT, MOYER JA, MUTH EA, SIGG EB: DMI, Wy-45,030, Wy-45,881 and ciramod inhibit locus ceruleus neuronal activity. Eur. J. PharmacoL (1985) 115:139–146.
   PubMed Web of Science ®Google Scholar
• FEIGHNER JP: Mechanism of action of antidepressant medications. J. Clin. Psychiatry. (1999) 60:(Suppl. 4):4–11.
   PubMed Web of Science ®Google Scholar
• PRESKORN SH: Antidepressant drug selection: criteria and options. J. Clin. Psychiatry. (1994) 55:(Suppl. A):6–22.
   PubMed Web of Science ®Google Scholar
• LANG E, HORD AH, DENSON D: Venlafaxine hydrochloride (EffexorTm) relieves thermal hyperalgesia in rats with an experimental mononeuropathy. Pain (1996) 68:151–155.
   PubMed Web of Science ®Google Scholar
• MARCHAND F, ALLOUI A, PELISSIER T et al: Evidence for an antihyperalgesic effect of venlafaxine in vincristine-induced neuropathy in rat. Brain Res. (2003) 980:117–120.
   PubMed Web of Science ®Google Scholar
• UYAR M, ONAL A, DOGRU A, SOYKAN N: The antinociceptive effect of Tramadol-Venlafaxine combination on the paw withdrawal threshold in a rat model of neuropathic pain. Methods Find Exp. Clin. PharmacoL (2003) 25:(5):361–365.
   PubMed Web of Science ®Google Scholar
• PERNIA A: Venlafaxine for the treatment of neuropathic pain. J. Pain. Symp. Manag. (2000) 19:408–410.
   PubMed Web of Science ®Google Scholar
• SUMPTON JE, MOULIN DE: Treatment of neuropathic pain with venlafaxine. Ann. Pharmacother. (2001) 35:557–559.
   PubMed Web of Science ®Google Scholar
• TAYLOR K, ROWBOTHAM MC: Venlafaxine hydrochloride and chronic pain. West. J. Med. (1996) 165:147–148.
   PubMedGoogle Scholar
• LITHNER F: Venlafaxine in treatment of severe painfitl peripheral diabetic neuropathy. Diabetes Care (2000) 23:1710–1711.
   PubMed Web of Science ®Google Scholar
• SIMMONS Z, FELDMAN EL: Update on diabetic neuropathy. Curr. Opin. NeuroL (2002) 15:595–603.
   PubMed Web of Science ®Google Scholar
• ASCHER JA, COLE JO, COLIN JN et al: Bupropion: a review of its mechanism of antidepressant activity. J. Clin. Psychiatry (1995) 56:395–401.
   PubMed Web of Science ®Google Scholar
• PRESKORN SH: Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine and venlafaxine. j Clin. Psychiatry (1995) 56:(Suppl. 0:S12–S21.
   Google Scholar
• DAVIDSON JRT, FRANCE RD: Bupropion in chronic low back pain. Clin. Psychiatry (1994) 55:362.
   PubMed Web of Science ®Google Scholar
• SEMENCHUK MR, DAVIS B: Efficacy of sustained-release bupropion in neuropathic pain: an open-label study. Clin. J. Pain (2000) 16:6–11.
   PubMed Web of Science ®Google Scholar
• SEMENCHUK MR, SHERMAN S, DAVIS B: Double-blind, randomized trial of bupropion SR for the treatment of neuropathic pain. Neurology (2001) 57:1583–1588.
   PubMed Web of Science ®Google Scholar
• RICE ASC, MATON S: Postherpetic Neuralgia Study Group. Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study. Pain (2001) 94:215–224.
   PubMed Web of Science ®Google Scholar
• MCQUAY H, CARROLL D, JADAD AR, WIFFEN P, MOORE A: Anticonvulsant drugs for management of pain: a systematic review. Br. Med. J. (1995) 311:1047–1052.
   PubMed Web of Science ®Google Scholar
• FIELDS HL, ROWBOTHAM MC, DEVOR M: Excitability blockers: anticonvulsants and low concentration local anaesthetics in the treatment of chronic pain. In: Handbook of experimental pharmacology. Dickenson A, Besson JM (Eds). Berlin: Springer-Verlag (1997):93–116.
   Google Scholar
• ROWBOTHAM MC, PETERSEN KI,, DAVIES PS, FRIEDMAN EK, FIELDS HL: Recent developments in the treatment of neuropathic pain. In Proceedings of the 9th World Congress on Pain. Progress in Pain Research and Management. : Devor M, Rowbotham MC, Wisenfeld-Hallin Z (Eds).Seattle: IASP Press, (2000) 16:833–855.
   Google Scholar
• KILLIAN JM, FROMM GH: Carbamazepine with treatment of neuralgia. Arch. Neurol (1968) 19:129–136.
   PubMed Web of Science ®Google Scholar
• DUNSKER SB, MAYFIELD FH: Carbamazepine in the treatment of the flashing pain syndrome. J. Neurosurg-. (1976) 45:49–51.
   PubMed Web of Science ®Google Scholar
• CHADDA VS, MATHUR MS: Double blind study of the effects of diphenylhydantoin sodium on diabetic neuropathy. J. Assoc. Physicians India (1978) 26:403–406.
   PubMedGoogle Scholar
• WILTON TD: Tegretol in the treatment of diabetic neuropathy. S. Aft. Med. J. (1974) 48:869–872.
   PubMed Web of Science ®Google Scholar
• ALBERT HH: Infusion therapy of acute trigeminal neuralgia using phenytoin i.v. MMW Muench Med. Wochenschr. (1978) 120:529–530.
   PubMedGoogle Scholar
• CHEUNG H, KAMP D, HARRIS E: An in vitro investigation of the action of lamotrigine on neuronal voltage-activated sodium channels. Epilepsy Res. (1992) 13:107–112.
   PubMed Web of Science ®Google Scholar
• TEOH H, FOWLER LJ, BOWERY NG: Effect of lamotrigine on the electrically-evoked release of endogenous amino acids from slices of dorsal horn of the rat spinal cord. Neuropharmacology (1995) 34:1273–1278.
   PubMed Web of Science ®Google Scholar
• HUNTER JC, GOGAS KR., HEDLEY LR: The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic pain. Eur. j Pharmacol (1997) 324:153–160.
   PubMed Web of Science ®Google Scholar
• NAKAMURA-CRAIG M, FOLLENFANT RL: Effect of lamotrigine in the acute and chronic hyperalgesia induced by PGE2 and in the chronic hyperalgesia in rats with streptozotocin-induced diabetes. Pain (1995) 63:33–37.
   PubMed Web of Science ®Google Scholar
• COLLINS SD, CLAYTON NM, NOBBS M, BOUNTRA C: The effect of lamotrigine and morphine on neuropathic pain in the rat. In: Proceedings of the 9th World Congress on Pain. Progress in Pain Research and Management. Devor M, Rowbotham MC, Wisenfeld-Hallin Z (Eds). Seattle: IASP Press, (2000) 16:281–285.
   Google Scholar
• ZAKRZEWSKA JM, CHAUDHRY Z, NURMIKKO TJ, PATTON DW, MULLENS EL: Lamotrigine (Lamictal) in refractory trigeminal neuralgia; results from a double-blind placebo controlled crossover trial. Pain (1997) 73:223–230.
   PubMed Web of Science ®Google Scholar
• EISENBERG E, ALON N: Lamotrigine inthe treatment of painful diabetic neuropathy. Abstracts:8th World Congress on Pain. Seattle: IASP Press, (1996) p372.
   Google Scholar
• CANAVERO S, BONICALZI V: Lamotrigine control of central pain. Pain (1996) 68:179–181.
   PubMed Web of Science ®Google Scholar
• JENSEN TS: Anticonvulsants in neuropathic pain: rationale and clinical evidence. Eur. J. Pain (2002) 6:(Suppl. A):61–68.
   PubMed Web of Science ®Google Scholar
• •Mechanistic analysis of the use of anticonvulsants in a range of neuropathies.
   Google Scholar
• BAJWA ZH, SAMI N, WARFIELD CA, WOOTTON J: Topiramate relieves refractory intercostals neuralgia. Neurology (1999) 52:1917.
   PubMed Web of Science ®Google Scholar
• EDWARDS KR, GLANTZ MJ, BUTTON J, NORTON JA, WHITTAKER T, CROSS N: Efficacy and safety of topiramate in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study. Neurology (2000) 54:(Suppl. 54):A81.
   Google Scholar
• GEE NS, BROWN JP, DISSANAYAKE VUK, OFFORD J, THURLOW R, WOODRUFF GN: The novel anticonvulsant drug, gabapentin (neurontin) binds to the a2ösubunit of a calcium channel. J. Biol. Chem. (1996) 271:5768–5776.
   PubMed Web of Science ®Google Scholar
• •First study to identify a potential mechanism of action for gabapentin.
   Google Scholar
• BACKONJA M-M, BEYDON A, EDWARDS KR et al.: for the Gabapentin Diabetic Neuropathy study group. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus. A randomised controlled trial.JA,VL4 (1998) 280: 1831–1836.
   Google Scholar
• ROWBOTHAM M, HARDEN N, STACEY B, BERNSTEIN P, MAGNUS-MILLER L: for the Gabapentin study group. Gabapentin for the treatment of postherpetic neuralgia. A randomised controlled trial. JAMA (1998) 280:1837–1842.
   PubMed Web of Science ®Google Scholar
• BACKONJA M-M: Local anesthetics as adjuvant analgesics. J. Pain Symp Manag-. (1994) 9: 491–499.
   Google Scholar
• •Thorough analysis of the potential of local anaesthetics in the treatment of neuropathic pain.
   Google Scholar
• BOAS RA, COUSINS M: Diagnostic neural blockade. In: Neural blockade in clinical anesthesia and management of pain. Cousins M, Bridenbaugh P, (Ed). Philadelphia: JB Lippincott, (1988):885–898.
   Google Scholar
• KASTRUP J, PETERSEN P, DEJGARD A, ANGELO HR, HILSTED J: Intravenous lidocaine infusion - a new treatment of chronic painful diabetic neuropathy. Pain (1987) 28:69–75.
   PubMed Web of Science ®Google Scholar
• ROWBOTHAM MC, REISNER-KELLER LA, FIELDS HL: Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia. Neurology (1991) 41:1024–1028.
   PubMed Web of Science ®Google Scholar
• MARCHETTINI P, LACERENZA M, MARANGONI G et al.: Lidocaine test in neuralgia. Pain (1992) 48:277–282.
   Web of Science ®Google Scholar
• WALLACE MS, DYCK JB, ROSSI SS, YAKSH TL: Computer-controlled lidocaine infusion for the evaluation of neuropathic pain after peripheral nerve injury. Pain (1996) 66:69–77.
   PubMed Web of Science ®Google Scholar
• ALBRIGHT GA: Cardiac arrest following regional anesthesia with etidocaine and bupivacaine. Anesthesiology (1950) 53:259.
   Google Scholar
• DEJGARD A, PETERSEN P, KASTRUP J: Mexiletine for treatment of chronic painful diabetic neuropathy. Lancet (1988) 2:9–11.
   Web of Science ®Google Scholar
• CHABAL C, JACOBSON L, MARIANO A, CHANEY E, BRITTELL CW: The use of oral mexilitine for the treatment of pain after peripheral nerve injury. Anesthesiology (1992) 76: 513–517.
   Google Scholar
• STRACKE H, MEYER U, SCHUMACHER HE, FEDERLIN K: Mexilitine in the treatment of diabetic neuropathy. Diabetes Care (1992) 15:1550–1555.
   PubMed Web of Science ®Google Scholar
• ROWBOTHAM MC, DAVIES PS, FIELDS HL: Topical lidocaine gel relieves postherpetic neuralgia. Ann. NeuroL (1995) 37:246–253.
   PubMed Web of Science ®Google Scholar
• ROWBOTHAM MC, DAVIES PS, VERKEMPINCK C, GALER BS: Lidociane patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia. Pain (1996) 65:39–44.
   PubMed Web of Science ®Google Scholar
• GALER BS, DWORKIN RH: A clinical guide to neuropathic pain. New York: McGraw Hill Companies, (2000).
   Google Scholar
• CHAD DA, ARONIN N, LUNDSTROM R et al.: Does capsaicin relieve the pain of diabetic neuropathy? Pain (1990) 42:387–388.
   PubMed Web of Science ®Google Scholar
• CAPSAICIN STUDY GROUP: Treatment of painful diabetic neuropathy with topical capsaicin, a multicenter, double-blind, vehicle-controlled study. Arch. Intern. Med. (1991) 151:2225–2229.
   PubMed Web of Science ®Google Scholar
• BERNSTEIN JE, KORMAN NE, BICKER DR, DAHL MV MILLIKAN LE: Topical capsaicin treatment of chronic postherpetic neuralgia./ Am. Acad. DermatoL (1989) 21:265–270.
   PubMed Web of Science ®Google Scholar
• WATSON CP, EVANS RJ: A comparative trial of amitriptyline and zimelidine in post-herpetic neuralgia. Pain (1985) 23:387–394.
   PubMed Web of Science ®Google Scholar
• BENEDITTIS GD, LORENZETTI A: Topical aspirin/diethyl ether mixture versus indomethacin and diclofenac/diethyl ether mixtures for acute herpetic neuralgia and postherpetic neuralgia: a double-blind crossover placebo-controlled study. Pain (1996) 65:45–51.
   PubMed Web of Science ®Google Scholar
• ARNER S, MEYERSON BA: Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain (1988) 33:11–23.
   PubMed Web of Science ®Google Scholar
• KUPERS RC, KONINGS H, ADRIAENSEN H, GYBELS GM: Morphine differentially affects the sensory and affective pain ratings in neurogenic and idiopathic forms of pain. Pain (1991) 47:5–12.
   PubMed Web of Science ®Google Scholar
• SINDRUP SH, ANDERSON G, MADSEN C et al.: Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial. Pain (1999) 83:85–90.
   PubMed Web of Science ®Google Scholar
• WATSON CPN, BABUL N: Efficacy of oxycodone in neuropathic pain. A randomized trial in postherpetic neuralgia. Neurology (1998) 50:1837–1841.
   PubMed Web of Science ®Google Scholar
• RAJA SN, HAYTHORNWAITE JA, PAPPAGALLO M et al.: Opioids versus antidepressants in postherpetic neuralgia: a randomized placebo-controlled trial. Neurology (2002) 59:1015–1021.
   PubMed Web of Science ®Google Scholar
• KALSO E: Opioids for chronic noncancer pain. In: Dostrovsky JO, Carr DB, Koltzenburg M (Eds). Proceedings of the 10th World Congress on Pain. Progress in Pain Research and Management. Seattle: IASP Press, (2003) 24:751–765.
   Google Scholar
• BENNETT GJ, XIE YK: A peripheral mononeuropathy in rats that produces disorders of pain sensation like those seen in man. Pain (1988) 33:87–107.
   PubMed Web of Science ®Google Scholar
• SELTZER Z, DUBNER R, SHIR Y: A novel behavioural model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain (1990) 43:205–218.
   PubMed Web of Science ®Google Scholar
• KIM SH, CHUNG JM: An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain (1992) 50:355–363.
   PubMed Web of Science ®Google Scholar
• KIM KJ, YOON YW, CHUNG JM: Comparison of three rodent neuropathic pain models. Exp. Brain Res. (1997) 113:200–206.
   PubMed Web of Science ®Google Scholar
• •Unique analysis of the behavioural time course and modalities of three commonly used animal models.
   Google Scholar
• KONTINEN VK, MEERT TF: Predictivevalidity of neuropathic pain models in pharmacological studies with a behavioural outcome in the rat: a systematic review. In: Dostrovsky JO, Carr DB, Koltzenburg M (Eds). Proceedings of the 10th World Congress on Pain. Progress in Pain Research and Management. Seattle: IASP Press, (2003) 24:489–498.
   Google Scholar
• COURTEIX C, ESCHALIER A, LAVARENNE J: Streptozocin-induced diabetic rats: behavioural evidence for a model of chronic pain. Pain (1993) 53:81–88.
   PubMed Web of Science ®Google Scholar
• FLEETWOOD-WLAKER SM, QUINN JP, WALLACE C et al: Behavioural changes in the rat following infection with varicella-zoster virus. J. Gen. Virology (1999) 80:2433–2436.
   PubMed Web of Science ®Google Scholar
• CUMMINS TR, DIB-HAJJ SD, BLACK JA, WAXMAN SG: Sodium channels as molecular targets in pain. In: Devor M, Rowbotham MC, Wisenfeld-Hallin Z (Eds). Proceedings of the 9th World Congress on Pain. Progress in Pain Research and Management. Seattle: IASP Press, (2000) 16:77–91.
   Google Scholar
• CATTERALL WA: Structure and functionof voltage-sensitive ion channels. Science (1988) 242:50–61.
   PubMed Web of Science ®Google Scholar
• CHUNG JM, DIB-HAJJ SD, LAWSON SN: Sodium channel subtypes and neuropathic pain. In: Dostrovsky JO, Carr DB, Koltzenburg M (Eds). Proceedings of the 10th World Congress on Pain. Progress in Pain Research and Management. Seattle: IASP Press, (2003) 24:99–114.
   Google Scholar
• FARAVELLI L, MAJ R, VENERONI O, FARIELLO RG, BENATTI L, SALVATI P: NW-1029 is a novel Na+ channel blocker with analgesic in animal models. Society for Neuroscience 30th Annual Meeting, New Orleans, LA, (2000) 26:(1):1218 (454.9).
   Google Scholar
• VENERONI O, MAJ R, CALABRESI M, FARAVELLI L, FARIELLO RG, SALVATI P: Anti-allodynic effect of NW-1029, a novel Na+ channel blocker, in experimental animal models of inflammatory and neuropathic pain. Pain (2003) 102:17–25.
   PubMed Web of Science ®Google Scholar
• •Animal experiments documenting a novel broad-spectrum analgesic.
   Google Scholar
• TSIEN RW, FOX AP, HESS P et al.: Multiple types of calcium channel in excitable cells. Soc. Gen. Physiol. Ser. (1987) 41:167–187.
   PubMedGoogle Scholar
• CURRIE KP, FOX AP: Comparison of N-and P/Q-type voltage-gated calcium channel current inhibition. J. Neuroscience (1997) 17:4570–4579.
   PubMed Web of Science ®Google Scholar
• WERMELING D, DRASS M, ELLIS D et al.: Pharmacokinetics and pharmacodynamics of intrathecal ziconotide in chronic pain patients. J. Clin. Pharmacol (2003) 43:624–636.
   PubMed Web of Science ®Google Scholar
• SAITO Y, KIRIHARAY, HASHIMOTO T, DOI K, NAKATANI T: Spinal antinociceptive effects of a new calcium channel blocker, AGS1164, in rats. Program No. 63.21. 2003 Abstract Waver/Itinerary Planner. Washington, DC: Society for Neuroscience (2003) Online.
   Google Scholar
• KOGANEI H, FUJITA S, IWAYAMA S et al.: Analgesic effects of a novel compound which possesses N-type calcium channel blocking activity. Program No. 656.2.2002 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience (2002) Online.
   Google Scholar
• STEFANI A, SPADONI F, BERNARDI G: Gabapentin inhibits calcium currents in isolated rat brain neurons. Neuropharmacol (1998) 37:83–91.
   PubMed Web of Science ®Google Scholar
• MEDER WP, DOOLEY DJ: Modulation of K*-induced synaptosomal calcium influx by gabapentin. Brain Res. (2000) 875:157–159.
   PubMed Web of Science ®Google Scholar
• DOOLEY DJ, DONOVAN CM, PUGSLEY TA: Stimulus-dependent modulation of PFIlnorepinephrine release from rat neocortical slices by gabapentin and pregabalin. JPET (2000) 295:1086–1093.
   PubMed Web of Science ®Google Scholar
• MARTIN L, RABASSEDA X, LEESON P, CASTANER J: Pregabalin. Antiepileptic. Drugs of the Future (1999) 24:862–870.
   Google Scholar
• FIELD MJ, MCCLEARY S, HUGHES J, SINGH L: Gabapentin and pregabalin, but not morphine and amitriptyline, block both static and dynamic components of mechanical allodynia induced by streptozocin in the rat. Pain (1999) 80:391–398.
   PubMed Web of Science ®Google Scholar
• TAYLOR CP, VARTANIAN MC: Profile of the anticonvulsant activity of CI-1008 (pregabalin) in animal models. Epilepsia (1997) 38:(Suppl. 8).
   PubMed Web of Science ®Google Scholar
• DUBNER R, RUDA MA: Activity-dependent neuronal plasticity following tissue injury and inflammation. Trends Neurosci. (1992) 15:(3):96–103.
   PubMed Web of Science ®Google Scholar
• PARSONS CG, DANYSZ W, QUACK G: Memantine is a clinically well tolerated N-merhyl-D-aspartate (NMDA) receptor antagonist - a review of preclinical data. Neuropharmacol (1999) 38:735–767.
   PubMed Web of Science ®Google Scholar
• EISENBERG E, LACROSS S, STRASSMAN AM: The clinically tested N-methyl-D-aspartate receptor antagonist memantine blocks and reverses thermal hyperalgesia in a rat model of painful mononeuropathy. Neurosci. Lett. (1995) 187:17–20.
   PubMed Web of Science ®Google Scholar
• HU LY, GUO J, MAGAR SS, FISCHER JB, BURKE HOWIE KJ, DURANT GJ: Synthesis and pharmacological evaluation of N-(2,5-disubstituted phenyl)-N-(3-substituted phenyl)N-methyl guanidines as N-methyl-D-aspartate receptor ion channel blockers. J. Med. Chem. (1997) 40: 4281–4289.
   Google Scholar
• FARKAS S, HORVATH C, NAGY J et al.: RGH-896 is a novel potent and selective NR2B-NMDA antagonist with efficacy in neuropathic pain models. Program No. 382.8.2003 Abstract Waver/Itinerary Planner. Washington, DC: Society for Neuroscience (2003) Online.
   Google Scholar
• CURTIS NR, DIGGLE HJ, KULAGOWSKI JJ et al.: Orally efficacious NR2B-selective NMDA receptor antagonists. Bioorganic Med. Chem. Lett. (2003) 13:697–700.
   PubMed Web of Science ®Google Scholar
• BORZA I, KOLOK S, GERE A et al.: Indole-2-carboxamides as novel NR2B selective NMDA receptor antagonists. Bioorganic Med. Chem. Lett. (2003) 13:3859–3861.
   PubMed Web of Science ®Google Scholar
• SANG CN, WEAVER JJ, JINGA L, WOUDEN J, SALTARELLI MD: The NR2B subunit-selective NMDA receptor antagonist, CP-101,606, reduces spontaneous pain intensity in patients with central and peripheral neuropathic pain. Program No. 814.9. 2003 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience (2003) Online.
   Google Scholar
• KARPA KD, CAVANAUGH JE, LAKOSKI J: Duloxetine pharmacology: profile of a dual monoamine modulator. CNS Drug Reviews (2002) 8:(4):361–376.
   PubMedGoogle Scholar
• WONG DT, BYMASTER FP, MAYLE DA, REID LR, KURSHINSKI JH, ROBERSTON DW: LY248686, a new inhibitor of serotonin and norepinephrine uptake. Neuropsychopharmacol. (1993) 8:23–33.
   PubMed Web of Science ®Google Scholar
• KASAMO K, BLIER P, DE MONTIGNY C. Blockade of the serotonin and norepinephrine uptake processes by duloxetine: In vitro and in vivo studies in the rat brain. J. PharmacolExp. Ther. (1996) 277:278–286.
   PubMed Web of Science ®Google Scholar
• SIMMONS RMA, SHANNON HE, WONG DT et al.: Efficacy of the selective serotonin and norepinephrine reuptake inhibitor, duloxetine, in persistent pain in rats. 10th World Congress on Pain. San Diego, USA (2002) 1156–P72.
   Google Scholar
• GOLDSTEIN DJ, MALLINCKRODT C, LU Y, DEMITRACK MA: Duloxetine: a potential new treatment for depressed patients with comorbid pain. J. Clin. Psych. (2002) 63:225–231.
   Web of Science ®Google Scholar
• SMITH CARLISS RD, SHUEY D, GERSON R, YAKSH T: Pharmacologic evaluation of the therapeutic potential of EN-3215, a novel 5-HT/NE reuptake inhibitor, in animal models of neuropathic pain. Program No. 589.19.2003 Abstract Waver/Itinerary Planner. Washington, DC: Society for Neuroscience (2003) Online.
   Google Scholar
• SAMAD TA, MOORE KA, SAPIRSTEIN A et al.: Interleukin-10-mediated induction of COX-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature (2001) 410:471–475.
   PubMed Web of Science ®Google Scholar
• WOOLF CJ, BENNETT GJ, DOHERTY M: Towards a mechanism-based classification of pain? Pain (1998) 77:227–229.
   PubMed Web of Science ®Google Scholar
• ••First paper to challenge the existingclassification of neuropathic pain and highlight the importance of a more mechanistic-based approach.
   Google Scholar
• CREAMER P, HUNT M, DIEPPE P: Pain mechanisms in osteoarthritis of the knee: effect of intrarticular anesthetic. Rheumatol (1996) 23:1031–1036.
   Web of Science ®Google Scholar
• BAJAJ P, BAJAJ P, GRAVEN-NIELSEN T, ARENDT-NIELSEN L: Osteoarthritis and its association with muscle hyperalgesia: an experimental controlled study. Pain (2001) 93:107–114.
   PubMed Web of Science ®Google Scholar
• LEFFLER AS, KOSEK E, LERNDAL T, NORDMARK B, HANNSON P: Somatosensory perception and function of diffuse noxious inhibitory controls (DNIC) in patients suffering from rheumatoid arthritis. Eur. J. Pain (2002) 6:161–176.
   PubMed Web of Science ®Google Scholar
• HENDIANI JA, WESTLUND KN, LAWAND N, GOEL N, LISSE J, MCNEARNEY T: Mechanical sensitisation and pain thresholds in patients with chronic arthropathies. J. Pain (2003) 4:203–211.
   PubMed Web of Science ®Google Scholar
• MELTON L: Osteoarthritis pain goes central. Lanc et Neurology (2003) 2:524.
   PubMed Web of Science ®Google Scholar
• •News article highlighting the possible involvement of central mechanisms in osteoarthritis.
   Google Scholar
• PETERSEN KL, FIELDS HL, BRENNUM J, SANDRONI P, ROWBOTHAM MC: Capsaicin evoked pain and allodyna in post-herpetic neuralgia. Pain (2000) 88:125–133.
   PubMed Web of Science ®Google Scholar
• PETERSEN KL, RICE FL, SUESS F, BERRO M, ROWBOTHAM MC: Relief of post-herpetic neuralgia by surgical removal of painful skin. Pain (2002) 98:119–126.
   PubMed Web of Science ®Google Scholar